Do no do examples

Do no do examples for Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer
Title Year published Impact Level
Bevacizumab in combination with a taxane is not recommended for the first-line treatment of metastatic breast cancer. February 2011 Unclassified